Article

Endogenous BMP-7 is a critical molecular determinant of the reversibility of obstruction-induced renal injuries

Department of Surgery, Division of Pediatric Urology, Washington University, 4990 Children's Place, St. Louis, MO 63110, USA.
AJP Renal Physiology (Impact Factor: 4.42). 08/2011; 301(6):F1293-302. DOI: 10.1152/ajprenal.00071.2011
Source: PubMed

ABSTRACT Although obstructive uropathies are frequently correctable through surgery, the potential for permanent renal injury remains even following the successful correction of obstructions. Little is known about the intrinsic mechanisms that determine the reversibility of renal injuries. We and others found that exogenous bone morphogenic protein 7 (BMP-7) inhibits the pathogenesis of renal injury. Here, we examine the role of endogenous BMP-7 in the outcome of renal recovery following the correction of obstructive uropathies using a reversible murine model of ureteral obstruction. The role of BMP-7 was determined by examining the regulation of BMP-7 during renal recovery and by treating with either BMP-7-neutralizing antibodies or exogenous BMP-7. While BMP-7 is upregulated following the correction of obstructions that lead to reversible renal injury, the upregulation of BMP-7 is diminished following the correction of prolonged obstructions that lead to irreversible renal injury. The activation of the BMP-7 pathway is required for several processes that contribute to renal recovery including the suppression of transforming growth factor-β-dependent profibrotic pathways, the restoration of renal architecture, and the resolution of fibrotic changes in the kidney. Importantly, the therapeutic restoration of BMP-7 enhances renal recovery following the correction of prolonged obstructions that typically lead to irreversible renal injury. Together, these findings show that, while BMP-7 plays a critical role in the repair of obstruction-induced renal injuries, the potential for renal recovery from prolonged obstruction is diminished, in part, due to the dysregulation of BMP-7. Accordingly, renal recovery from obstructive uropathies may be optimized through timely intervention and adjuvant approaches to restore BMP-7 activity.

0 Followers
 · 
90 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Within the developing mammalian kidney, several populations of progenitors form the discrete cellular components of the final organ. Fate mapping experiments revealed the cap mesenchyme (CM) to be the progenitor population for all nephron epithelial cells, whereas the neighboring stromal mesenchyme gives rise to mesangial, pericytic, renin-producing and interstitial cells. The collecting ducts are derived from a population of progenitors at the ureteric bud (UB) tip and a proportion of the endothelium is also derived from a dedicated mesenchymal progenitor. The stroma, CM, and UB interact to create spatially defined niches at the periphery of the developing organ. While the UB tip population persist, the CM represents a transient progenitor population that is exhausted to set the final organ size. The timing of CM exhaustion, and hence the final organ structure, is sensitive to disruptions such as premature birth. Here we will discuss our current understanding of the molecular processes allowing these populations to balance cell survival, self-renewal, support of branching, and maintain capacity to commit to differentiation.
    Current Topics in Developmental Biology 01/2014; 107C:293-331. DOI:10.1016/B978-0-12-416022-4.00011-1 · 4.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recombinant BMP-7 inhibits the pathogenesis of renal injury in response to a variety of stimuli. However, little is known about the molecular regulation of endogenous BMP-7 and its renal protective functions. This study examines the transcriptional regulation of Bmp-7 and its role in the pathogenesis of renal injuries resulting from urinary tract dysfunction. Obstruction-induced renal injury was modeled in vivo in mice by unilateral ureteral obstruction (UUO) and in vitro in primary kidney cells by treatment with TGF-β, a pro-fibrotic cytokine that is elevated in the obstructed kidney. UUO results in the loss of BMP-7 expression in conjunction with histone deacetylation and transcriptional repression of the Bmp-7 promoter. The histone deacetylase (HDAC) inhibitor trichostatin A (TSA) stimulates Bmp-7 expression in primary kidney cells. Furthermore, TSA inhibits the expression of TGF-β-dependent pro-fibrotic genes in a manner that is dependent upon BMP receptor signaling. These findings extend to the obstructed kidney in vivo where treatment with TSA restores the expression of Bmp-7 along with the BMP-7-mediated suppression of TGF-β-dependent signaling pathways. Finally, the TSA-stimulated activation of the BMP-7 pathway ameliorates obstruction-induced renal injuries by preventing the disruption of renal architecture and the development of renal fibrosis. Together, these findings demonstrate that the HDAC-dependent repression of Bmp-7 transcription is a critical event during the pathogenesis of renal injury in obstructive uropathies. Accordingly, treatment with HDAC inhibitors represents a potentially effective strategy to restore BMP-7 expression and its renal protective functions during the treatment of obstructive uropathies.
    The Journal of urology 06/2013; 191(1). DOI:10.1016/j.juro.2013.06.110 · 3.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Paeoniflorin (PF), the major active constituent of Paeonia lactiflora Pallas, has previously been reported to alleviate hepatic fibrosis. Whether and how it affects renal fibrosis was evaluated in the present study. The experimental renal fibrosis was induced by unilateral ureteral obstruction (UUO) operation in mice, and PF was orally administered for consecutive 7 days. Renal interstitial destruction and fibrosis degree were evaluated by histopathological examination and hydroxyproline assay. It was shown that PF treatment markedly ameliorated renal interstitial fibrotic lesions, attenuated synthesis of collagen and plasminogen activator inhibitor-1 (PAI-1), an important inhibitor of extracellular matrix degrading enzymes, in UUO mice. PF also suppressed epithelial-mesenchymal transition (EMT) by down-regulating TGF-β1 expression and maintaining BMP-7 mRNA expression, and inhibited Smad2/3 activation in fibrotic kidneys induced by UUO. These observations suggest that PF can effectively prevent renal interstitial fibrosis, and the underlying mechanisms are, at least in part, through blocking EMT via BMP-7 recovery and TGF-β/Smad signaling inhibition.
    Phytomedicine: international journal of phytotherapy and phytopharmacology 03/2013; DOI:10.1016/j.phymed.2013.02.010 · 2.88 Impact Factor